Jeanette McCarthy

 

 


 

Jeanette McCarthy, MPH, PhD is an Adjunct Associate Professor at the Duke University Center for Personalized and Precision Medicine and a Visiting Associate Professor of Medicine at the University of California San Francisco, division of medical genetics. At Duke, she works closely with Dr. Geoffrey Ginsburg on educational initiatives in Genomic and Personalized Medicine. She is Editor-in-Chief of the Center’s website, which is a portal for the latest information on advances in the field of genomic and personalized medicine. At UCSF, she currently leads the effort to develop and implement a framework for precision medicine education. In addition to her academic appointments, she is Editor-in-Chief of a new patient-centered magazine from Big Science Media, called Genome, aimed at educating and informing patients in the area of precision medicine (launching April 2014).

Dr. McCarthy trained as a genetic epidemiologist at UC Berkeley under geneticist Mary-Claire King, and subsequently as a Fulbright post-doctoral fellow in Barcelona, and has spent her career in both academia and industry (Millennium Pharmaceuticals). Her academic research on the genetic underpinnings of infectious and chronic diseases has led to over 50 publications in peer-reviewed journals. She recently co-authored a comprehensive review on the field of genomic medicine, published in Science Translational Medicine. Professor McCarthy is a passionate educator and has developed and taught courses in her field both nationally and internationally, and received a Golden Apple Award for her teaching at San Diego State University.

More info: https://sites.google.com/site/precisionmedicineadvisorscom/about-us/jean...




Customize your search:

E.g., 2017-09-08
E.g., 2017-09-08
E.g., 2017-09-08
Sep 4th 2017

Precision medicine has the potential to change fundamentally how health care is practiced, but requires a health care workforce that understands the complexities of this field. One important component of Precision Medicine is the use of an individual’s genomic information to offer targeted treatment, tailored to the individual. Our course aims to provide participants with some baseline knowledge of genomics, an overview of the clinical applications of genomic medicine, the skills to evaluate the clinical validity and utility of new tests, and an appreciation of the associated ethical and social issues inherent in this field.

Average: 5.3 (3 votes)